chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Large intestine polyp, Rectal haemorrhage
Clinical narrative: Patient ID:   Admit Date:  8/30/2022   Discharge Date: 9/2/22   Principal Dx/ Final Dx: BRBPR (bright red blood per rectum)   Relevant Inpt Dx: Principal Problem:   BRBPR (bright red blood per rectum) Active Problems:   COVID-19 virus infection   Essential hypertension   Atrial fibrillation       HPI:   Hospital Course:   This 71 year old man was admitted with GI bleeding.  He was seen by GI and his xarelto was held.  Bleeding felt to be lower GI bleeding.  Colonoscopy showed extensive diverticulosis and one polyp.   Source of bleeding felt diverticular . He has been cleared by GI to resume his xarelto.     He has a fib and did have some rapid rate due to missed medications.  He is back on home meds now.     hgb today is 10.8.  Repeat cbc next week.     @HOSPDCED@   Consults:   IP CONSULT TO GASTROENTEROLOGY IP CONSULT TO SOCIAL WORK     Disposition:  home   Discharge Condition:  fair
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: no adverse event reported
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Sore at the injection site in her left arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 vaccination: Flu shot in October 2021; for Product used for unknown indication: Allegra. Past adverse reactions to the above products included Bone disorder with Allegra; and No adverse event with Flu shot. Concurrent medical conditions included Blood pressure high, Cholesterol, Antihistamine therapy and Seasonal allergy (summer allergies). Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, LISINOPRIL for Blood pressure high, ROSUVASTATIN for Cholesterol, GLIPIZIDE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue). On 16-Feb-2021, VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication was reported. Patient had never COVID positive test or diagnosis. No medical history was relating to mentioned AE and both acute and Chronic illnesses at the time of vaccination. It was reported that patient did not seek for medical care for AE. It was reported that many years ago she took Allegra D but it kind of dried her bones out, so she started to take Cetirizine. Patient could barely walk in yesterday.   This case was linked to MOD-2022-638956, MOD-2022-638958 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore at the injection site in her left arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 vaccination: Flu shot in October 2021; for Product used for unknown indication: Allegra. Past adverse reactions to the above products included Bone disorder with Allegra; and No adverse event with Flu shot. Concurrent medical conditions included Blood pressure high, Cholesterol, Antihistamine therapy and Seasonal allergy (summer allergies). Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, LISINOPRIL for Blood pressure high, ROSUVASTATIN for Cholesterol, GLIPIZIDE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue). On 16-Feb-2021, VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication was reported. Patient had never COVID positive test or diagnosis. No medical history was relating to mentioned AE and both acute and Chronic illnesses at the time of vaccination. It was reported that patient did not seek for medical care for AE. It was reported that many years ago she took Allegra D but it kind of dried her bones out, so she started to take Cetirizine. Patient could barely walk in yesterday.   This case was linked to MOD-2022-638956, MOD-2022-638958 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Bone pain, Fatigue, Gait disturbance
Clinical narrative: Sore at the injection site in her left arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 vaccination: Flu shot in October 2021; for Product used for unknown indication: Allegra. Past adverse reactions to the above products included Bone disorder with Allegra; and No adverse event with Flu shot. Concurrent medical conditions included Blood pressure high, Cholesterol, Antihistamine therapy and Seasonal allergy (summer allergies). Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, LISINOPRIL for Blood pressure high, ROSUVASTATIN for Cholesterol, GLIPIZIDE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue). On 16-Feb-2021, VACCINATION SITE PAIN (Sore at the injection site in her left arm) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication was reported. Patient had never COVID positive test or diagnosis. No medical history was relating to mentioned AE and both acute and Chronic illnesses at the time of vaccination. It was reported that patient did not seek for medical care for AE. It was reported that many years ago she took Allegra D but it kind of dried her bones out, so she started to take Cetirizine. Patient could barely walk in yesterday.   This case was linked to MOD-2022-638956, MOD-2022-638958 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: sore in the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (sore in the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Previously administered products included for Allergy: Allegra (many years ago she took Allegra D but it kind of dried her bones out and so she started to take Cetirizine). Past adverse reactions to the above products included Bone disorder (NOS) with Allegra. Concurrent medical conditions included Seasonal allergy (Summer allergies), Blood pressure high and Blood cholesterol abnormal. Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, ROSUVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure high, GLIPIZIDE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore in the injection site). The patient was treated with DICLOFENAC for Injection site pain, at an unspecified dose and frequency. On 14-Mar-2021, VACCINATION SITE PAIN (sore in the injection site) had resolved.    After 2nd dose, the patient experienced sore in the injection site only during the same day the vaccine was given. Treatment given for her symptoms right after the vaccines was Diclofenac. It was reported that On Oct2021, the patient had flu shot. This case was linked to MOD-2022-638953, MOD-2022-638958 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore in the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (sore in the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Previously administered products included for Allergy: Allegra (many years ago she took Allegra D but it kind of dried her bones out and so she started to take Cetirizine). Past adverse reactions to the above products included Bone disorder (NOS) with Allegra. Concurrent medical conditions included Seasonal allergy (Summer allergies), Blood pressure high and Blood cholesterol abnormal. Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, ROSUVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure high, GLIPIZIDE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore in the injection site). The patient was treated with DICLOFENAC for Injection site pain, at an unspecified dose and frequency. On 14-Mar-2021, VACCINATION SITE PAIN (sore in the injection site) had resolved.    After 2nd dose, the patient experienced sore in the injection site only during the same day the vaccine was given. Treatment given for her symptoms right after the vaccines was Diclofenac. It was reported that On Oct2021, the patient had flu shot. This case was linked to MOD-2022-638953, MOD-2022-638958 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Bone pain, Fatigue, Gait disturbance
Clinical narrative: sore in the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (sore in the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Previously administered products included for Allergy: Allegra (many years ago she took Allegra D but it kind of dried her bones out and so she started to take Cetirizine). Past adverse reactions to the above products included Bone disorder (NOS) with Allegra. Concurrent medical conditions included Seasonal allergy (Summer allergies), Blood pressure high and Blood cholesterol abnormal. Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, ROSUVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure high, GLIPIZIDE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore in the injection site). The patient was treated with DICLOFENAC for Injection site pain, at an unspecified dose and frequency. On 14-Mar-2021, VACCINATION SITE PAIN (sore in the injection site) had resolved.    After 2nd dose, the patient experienced sore in the injection site only during the same day the vaccine was given. Treatment given for her symptoms right after the vaccines was Diclofenac. It was reported that On Oct2021, the patient had flu shot. This case was linked to MOD-2022-638953, MOD-2022-638958 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: she could barely walk; joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders; Fatigue; Bone aches; This spontaneous case was reported by a patient and describes the occurrence of BONE PAIN (Bone aches), GAIT DISTURBANCE (she could barely walk), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002M21A, 025D21A and 031L20A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Flu shot in October 2021 and Allegra. Past adverse reactions to the above products included Bone disorder with Allegra; and No adverse event with Flu shot. Concurrent medical conditions included Blood cholesterol abnormal, Blood pressure high and Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, ROSUVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure high, GLIPIZIDE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2022, the patient experienced BONE PAIN (Bone aches), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue). On 01-Sep-2022, the patient experienced GAIT DISTURBANCE (she could barely walk). At the time of the report, BONE PAIN (Bone aches), GAIT DISTURBANCE (she could barely walk), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue) had not resolved.            Patient took Cetirizine Hydrochloride for Antihistamine. She took Allegra D but it kind of dried her bones out, so she started to take Cetirizine.  It was reported that After 1st and 2nd booster patient did not experienced any symptoms. On 24Aug 2022 patient started feeling bones and joints ache, in her knees, ankles, elbows, shoulders, and fatigue, with no apparent reason, not even due to exercise. These symptoms were still ongoing at the time of reporting, yesterday she could barely walk. Patient never had COVID + test or diagnosis Patient did not had both Acute and Chronic illnesses and relating to mentioned AE at the time of vaccination.   This case was linked to MOD-2022-638953, MOD-2022-638956 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: she could barely walk; joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders; Fatigue; Bone aches; This spontaneous case was reported by a patient and describes the occurrence of BONE PAIN (Bone aches), GAIT DISTURBANCE (she could barely walk), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002M21A, 025D21A and 031L20A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Flu shot in October 2021 and Allegra. Past adverse reactions to the above products included Bone disorder with Allegra; and No adverse event with Flu shot. Concurrent medical conditions included Blood cholesterol abnormal, Blood pressure high and Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, ROSUVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure high, GLIPIZIDE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2022, the patient experienced BONE PAIN (Bone aches), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue). On 01-Sep-2022, the patient experienced GAIT DISTURBANCE (she could barely walk). At the time of the report, BONE PAIN (Bone aches), GAIT DISTURBANCE (she could barely walk), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue) had not resolved.            Patient took Cetirizine Hydrochloride for Antihistamine. She took Allegra D but it kind of dried her bones out, so she started to take Cetirizine.  It was reported that After 1st and 2nd booster patient did not experienced any symptoms. On 24Aug 2022 patient started feeling bones and joints ache, in her knees, ankles, elbows, shoulders, and fatigue, with no apparent reason, not even due to exercise. These symptoms were still ongoing at the time of reporting, yesterday she could barely walk. Patient never had COVID + test or diagnosis Patient did not had both Acute and Chronic illnesses and relating to mentioned AE at the time of vaccination.   This case was linked to MOD-2022-638953, MOD-2022-638956 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Bone pain, Fatigue, Gait disturbance
Clinical narrative: she could barely walk; joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders; Fatigue; Bone aches; This spontaneous case was reported by a patient and describes the occurrence of BONE PAIN (Bone aches), GAIT DISTURBANCE (she could barely walk), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002M21A, 025D21A and 031L20A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Flu shot in October 2021 and Allegra. Past adverse reactions to the above products included Bone disorder with Allegra; and No adverse event with Flu shot. Concurrent medical conditions included Blood cholesterol abnormal, Blood pressure high and Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE for Antihistamine therapy, ROSUVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure high, GLIPIZIDE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2022, the patient experienced BONE PAIN (Bone aches), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue). On 01-Sep-2022, the patient experienced GAIT DISTURBANCE (she could barely walk). At the time of the report, BONE PAIN (Bone aches), GAIT DISTURBANCE (she could barely walk), ARTHRALGIA (joint aches / pain in the knees / pain in the ankles / pain in the elbows / pain in the shoulders) and FATIGUE (Fatigue) had not resolved.            Patient took Cetirizine Hydrochloride for Antihistamine. She took Allegra D but it kind of dried her bones out, so she started to take Cetirizine.  It was reported that After 1st and 2nd booster patient did not experienced any symptoms. On 24Aug 2022 patient started feeling bones and joints ache, in her knees, ankles, elbows, shoulders, and fatigue, with no apparent reason, not even due to exercise. These symptoms were still ongoing at the time of reporting, yesterday she could barely walk. Patient never had COVID + test or diagnosis Patient did not had both Acute and Chronic illnesses and relating to mentioned AE at the time of vaccination.   This case was linked to MOD-2022-638953, MOD-2022-638956 (Patient Link).
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, COVID-19, Chest X-ray normal, Condition aggravated
Clinical narrative: 60 y.o.       Admit Date:  8/31/2022     Discharge Date: 9/2/22     Principal Dx/ Final Dx:  Hypotension due to drugs     Relevant Inpt Dx:  Principal Problem:    Hypotension due to drugs  Active Problems:    COVID    AKI (acute kidney injury)    Essential hypertension    PAD (peripheral artery disease)           HPI:     Hospital Course:    This 60 year old man was admitted with hypotension and AKI.  He was given ivf and multiple BP meds were held.  He is improved today.  AKI has resolved.  Creatinine was 2.1 on admission and is 1.1 today.  He will resume his coreg.  His nifedipine and zestoretic are still held.  He will follow up with pcp in a week and re assess BP.  I have also held mobic due to aki and covid.       He did test positive for covid and did receive steroids and remdesivir.  He is not hypoxic, CXR ok, and lungs are clear so would not give further treatment              @HOSPDCED@     Consults:    IP CONSULT TO SOCIAL WORK           Disposition:  home     Discharge Condition:  fair
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, SARS-CoV-2 test positive
Clinical narrative: 60 y.o.       Admit Date:  8/31/2022     Discharge Date: 9/2/22     Principal Dx/ Final Dx:  Hypotension due to drugs     Relevant Inpt Dx:  Principal Problem:    Hypotension due to drugs  Active Problems:    COVID    AKI (acute kidney injury)    Essential hypertension    PAD (peripheral artery disease)           HPI:     Hospital Course:    This 60 year old man was admitted with hypotension and AKI.  He was given ivf and multiple BP meds were held.  He is improved today.  AKI has resolved.  Creatinine was 2.1 on admission and is 1.1 today.  He will resume his coreg.  His nifedipine and zestoretic are still held.  He will follow up with pcp in a week and re assess BP.  I have also held mobic due to aki and covid.       He did test positive for covid and did receive steroids and remdesivir.  He is not hypoxic, CXR ok, and lungs are clear so would not give further treatment              @HOSPDCED@     Consults:    IP CONSULT TO SOCIAL WORK           Disposition:  home     Discharge Condition:  fair
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Culture urine, Metabolic encephalopathy, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Patient ID:      83 y.o.       Admit Date:  8/31/2022     Discharge Date: 9/3/22     Principal Dx/ Final Dx:  Metabolic encephalopathy     Relevant Inpt Dx:  Principal Problem:    Metabolic encephalopathy           HPI:     Hospital Course:    This elderly woman was admitted with acute metabolic encephalopathy.  She tested positive for covid.  She had not tolerated paxlovid and did get 3 days remdesivir here.  Today she is off oxygen and her lungs are clear.  She also had UTI and did get empiric antibiotics.  Urine culture not yet resulted.  Plan for discharge to a HCF and follow up pcp.                     Consults:    IP CONSULT TO SOCIAL WORK           Disposition:  SNF     Discharge Condition:  fair
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: A nurse administerd 0.2ml, an additional dose of 0.05ml was offered immediately  to make up the full dose  but parent declined
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Breast cancer female, COVID-19, Hypoxia, Oestrogen receptor assay negative
Clinical narrative: Patient ID:   72 y.o.     Admit Date:  9/1/2022     Discharge Date: 9/4/22     Principal Dx/ Final Dx:  COVID-19     Relevant Inpt Dx:  Principal Problem:    COVID-19  Active Problems:    Acute respiratory failure with hypoxia    Type 2 diabetes mellitus    Malignant neoplasm of upper-outer quadrant of right breast in female, estrogen receptor negative           HPI:     Hospital Course:    This72 year old woman with breast cancer was admitted with covid.  She had hypoxia.  She did get remdesivir and steroids.  Today her lungs are without wheezing and she is not hypoxic on room air.  She will complete steroids orally.  She will call oncology beginning of week about next chemo treatment.        She does have diabetes and will resume home diabetes medications.              Consults:    IP CONSULT TO SOCIAL WORK        Disposition:  home     Discharge Condition:  fair
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Type 2 diabetes mellitus
Clinical narrative: Patient ID:   72 y.o.     Admit Date:  9/1/2022     Discharge Date: 9/4/22     Principal Dx/ Final Dx:  COVID-19     Relevant Inpt Dx:  Principal Problem:    COVID-19  Active Problems:    Acute respiratory failure with hypoxia    Type 2 diabetes mellitus    Malignant neoplasm of upper-outer quadrant of right breast in female, estrogen receptor negative           HPI:     Hospital Course:    This72 year old woman with breast cancer was admitted with covid.  She had hypoxia.  She did get remdesivir and steroids.  Today her lungs are without wheezing and she is not hypoxic on room air.  She will complete steroids orally.  She will call oncology beginning of week about next chemo treatment.        She does have diabetes and will resume home diabetes medications.              Consults:    IP CONSULT TO SOCIAL WORK        Disposition:  home     Discharge Condition:  fair
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Auscultation, COVID-19, Cardiac stress test abnormal, Disorientation
Clinical narrative: MD (Physician) Hospitalist          Physician Discharge Summary     Patient ID:   72 y.o.       Admit Date:  9/2/2022     Discharge Date:   9/5/2022     Discharge Diagnosis:  Principal Problem:    NSTEMI (non-ST elevated myocardial infarction)  Active Problems:    PAF (paroxysmal atrial fibrillation)    COVID-19 virus detected    Dementia without behavioral disturbance    Essential hypertension        Hospital Course:  72 year old female with dementia was admitted for NSTEMI and testing (+) for Covid-19. Cardiology saw her and stress test showed low risk and TTE showed normal LVEF. She has been ambulating and not hypoxic. She will be discharged home today in stable condition. Follow up with Primary Care Doctor in 5-7 days.     Physical Exam on the day of discharge:  Last Recorded Vital Signs: Temp: 98 °F (36.7 °C)  Heart Rate (Monitor): 71  Pulse: 72  BP: 125/67  Respirations: 18  SpO2: 94 %  O2 Flow Rate (l/min): 0 l/min  General Appearance: no distress   Eyes: PERRLA  ENT: moist mucus membranes, no adenopathy  Lungs: clear to auscultation bilaterally   Heart: irregular rate and rhythm  Abdomen: soft, non-tender   Skin: No rashes or lesions   Extremities: full ROM  Neuro: disoriented     Consults:  IP CONSULT TO CARDIOLOGY  IP CONSULT TO CARDIOLOGY  IP CONSULT TO SOCIAL WORK     Significant Diagnostic Studies:   Stress test, TTE     Operations: none     Disposition:  Home      Discharge Condition:  Fair
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram, Ejection fraction, Heart rate irregular, SARS-CoV-2 test positive
Clinical narrative: MD (Physician) Hospitalist          Physician Discharge Summary     Patient ID:   72 y.o.       Admit Date:  9/2/2022     Discharge Date:   9/5/2022     Discharge Diagnosis:  Principal Problem:    NSTEMI (non-ST elevated myocardial infarction)  Active Problems:    PAF (paroxysmal atrial fibrillation)    COVID-19 virus detected    Dementia without behavioral disturbance    Essential hypertension        Hospital Course:  72 year old female with dementia was admitted for NSTEMI and testing (+) for Covid-19. Cardiology saw her and stress test showed low risk and TTE showed normal LVEF. She has been ambulating and not hypoxic. She will be discharged home today in stable condition. Follow up with Primary Care Doctor in 5-7 days.     Physical Exam on the day of discharge:  Last Recorded Vital Signs: Temp: 98 °F (36.7 °C)  Heart Rate (Monitor): 71  Pulse: 72  BP: 125/67  Respirations: 18  SpO2: 94 %  O2 Flow Rate (l/min): 0 l/min  General Appearance: no distress   Eyes: PERRLA  ENT: moist mucus membranes, no adenopathy  Lungs: clear to auscultation bilaterally   Heart: irregular rate and rhythm  Abdomen: soft, non-tender   Skin: No rashes or lesions   Extremities: full ROM  Neuro: disoriented     Consults:  IP CONSULT TO CARDIOLOGY  IP CONSULT TO CARDIOLOGY  IP CONSULT TO SOCIAL WORK     Significant Diagnostic Studies:   Stress test, TTE     Operations: none     Disposition:  Home      Discharge Condition:  Fair
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asthma, COVID-19, Condition aggravated
Clinical narrative: Patient ID:   86 y.o.  10/23/1935     Admit Date:  9/2/2022     Discharge Date:   9/6/2022     Discharge Diagnosis:  Principal Problem:    Moderate persistent asthma with acute exacerbation  Active Problems:    Weakness    COVID-19 virus detected    Essential hypertension    Type 2 diabetes mellitus without complication, with long-term current use of insulin        Hospital Course:  86 year old female was admitted for asthma exacerbation and started on steroids. She recently contracted Covid-19 and was treated at home with Paxlovid. She was not given Remdesivir during this admission. She has now recovered and will be transferred today for rehab. Patient educated on appropriate level of care post-discharge. Follow up with Primary Care Doctor in 5-7 days.     Physical Exam on the day of discharge:  Last Recorded Vital Signs: Temp: 98 °F (36.7 °C)  Pulse: 88  BP: 135/54  Respirations: 18  SpO2: 100 %  O2 Flow Rate (l/min): 0 l/min        Consults:  IP CONSULT TO SOCIAL WORK     Significant Diagnostic Studies:   CXR     Operations: none     Disposition:  SNF     Discharge Condition:  Fair
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Asthenia, COVID-19, Dehydration
Clinical narrative: Age: 77 y.o.   Admit Date:  9/2/2022     Discharge Date:  9/9/2022      Principal Diagnosis: AKI (acute kidney injury)     Discharge Diagnoses:   Principal Problem:    AKI (acute kidney injury)  Active Problems:    Malignant neoplasm of left lung    Dehydration    Moderate protein-calorie malnutrition        Hospital Course:   Patient is a 77-year-old male with COPD, GERD,A fib, h/o mechanical heart valve, hypertension,?dementia, lung mass who presented with weakness, falls. Patient recently tested positive for COVID-19. In the ER he was noted to be clinically dehydrated with hypotension and acute renal failure. He was placed on IV fluids and renal function normalized prior to discharge.   INR was reversed with vitamin K and he was placed on a Heparin-Coumadin bridge. INR at discharge was 3.9 down from 10.4 on admission.  Patient was debilitated and discharged to rehab facility.  He had workup of lung mass initiated outpatient PTA and will need to continue to follow with provider after rehabilitation.      Discharge Exam:       Vitals:        09/09/22 1508    BP:        Pulse:        Resp:   18    Temp:           CVS: RRR  Resp: Clear lungs bilaterally  Abd: soft, non tender     Consults:  IP CONSULT TO SOCIAL WORK     Significant Diagnostic Studies:   labs: as above     Operations: none     Disposition:  SNF     Discharge Condition:  fair
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hypotension, International normalised ratio increased, Lung neoplasm malignant, Malnutrition
Clinical narrative: Age: 77 y.o.   Admit Date:  9/2/2022     Discharge Date:  9/9/2022      Principal Diagnosis: AKI (acute kidney injury)     Discharge Diagnoses:   Principal Problem:    AKI (acute kidney injury)  Active Problems:    Malignant neoplasm of left lung    Dehydration    Moderate protein-calorie malnutrition        Hospital Course:   Patient is a 77-year-old male with COPD, GERD,A fib, h/o mechanical heart valve, hypertension,?dementia, lung mass who presented with weakness, falls. Patient recently tested positive for COVID-19. In the ER he was noted to be clinically dehydrated with hypotension and acute renal failure. He was placed on IV fluids and renal function normalized prior to discharge.   INR was reversed with vitamin K and he was placed on a Heparin-Coumadin bridge. INR at discharge was 3.9 down from 10.4 on admission.  Patient was debilitated and discharged to rehab facility.  He had workup of lung mass initiated outpatient PTA and will need to continue to follow with provider after rehabilitation.      Discharge Exam:       Vitals:        09/09/22 1508    BP:        Pulse:        Resp:   18    Temp:           CVS: RRR  Resp: Clear lungs bilaterally  Abd: soft, non tender     Consults:  IP CONSULT TO SOCIAL WORK     Significant Diagnostic Studies:   labs: as above     Operations: none     Disposition:  SNF     Discharge Condition:  fair
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Renal function test, SARS-CoV-2 test positive
Clinical narrative: Age: 77 y.o.   Admit Date:  9/2/2022     Discharge Date:  9/9/2022      Principal Diagnosis: AKI (acute kidney injury)     Discharge Diagnoses:   Principal Problem:    AKI (acute kidney injury)  Active Problems:    Malignant neoplasm of left lung    Dehydration    Moderate protein-calorie malnutrition        Hospital Course:   Patient is a 77-year-old male with COPD, GERD,A fib, h/o mechanical heart valve, hypertension,?dementia, lung mass who presented with weakness, falls. Patient recently tested positive for COVID-19. In the ER he was noted to be clinically dehydrated with hypotension and acute renal failure. He was placed on IV fluids and renal function normalized prior to discharge.   INR was reversed with vitamin K and he was placed on a Heparin-Coumadin bridge. INR at discharge was 3.9 down from 10.4 on admission.  Patient was debilitated and discharged to rehab facility.  He had workup of lung mass initiated outpatient PTA and will need to continue to follow with provider after rehabilitation.      Discharge Exam:       Vitals:        09/09/22 1508    BP:        Pulse:        Resp:   18    Temp:           CVS: RRR  Resp: Clear lungs bilaterally  Abd: soft, non tender     Consults:  IP CONSULT TO SOCIAL WORK     Significant Diagnostic Studies:   labs: as above     Operations: none     Disposition:  SNF     Discharge Condition:  fair
Age: 90.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Abdominal discomfort, Back pain, Chest pain, Electrocardiogram normal, Laboratory test normal
Clinical narrative: Pt started feeling an upset stomach the morning after the vaccines (9/8 ~10AM) this then progressed to sharp pains in the chest and back in the evening towards the next morning (9/9). pt stated it hurt when he breathed in so he went to the ER on 9/9 at 3:30 PM and had a full workup to evaluate heart conditions, EKG, checked his a-fib, looked at arteries and everything came back fine. Was told to call the pharmacy to evaluate the possibility of the vaccines since nothing else made sense.
Age: 90.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Painful respiration
Clinical narrative: Pt started feeling an upset stomach the morning after the vaccines (9/8 ~10AM) this then progressed to sharp pains in the chest and back in the evening towards the next morning (9/9). pt stated it hurt when he breathed in so he went to the ER on 9/9 at 3:30 PM and had a full workup to evaluate heart conditions, EKG, checked his a-fib, looked at arteries and everything came back fine. Was told to call the pharmacy to evaluate the possibility of the vaccines since nothing else made sense.
Age: 36.0
Sex: M
Vaccine: COVID19-2
Symptoms: Back pain
Clinical narrative: Severe back pain, started at the mid lower lumber and now mid and lower vertebrae.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, UNK
Symptoms: Blood test, Computerised tomogram, Confusional state, Dysarthria, Facial pain
Clinical narrative: Blurry vision, confusion, nerve issues on side of body, ... ended up in er 5x after 3rd vaccine.  Severe head/nerve pain on left side of neck, jaw, face. Left foot drop. Left arm numb.  Slurred speech. Trigeminal neuralgia diagnosis
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, UNK
Symptoms: Headache, Hypoaesthesia, Magnetic resonance imaging, Neck pain, Nerve injury
Clinical narrative: Blurry vision, confusion, nerve issues on side of body, ... ended up in er 5x after 3rd vaccine.  Severe head/nerve pain on left side of neck, jaw, face. Left foot drop. Left arm numb.  Slurred speech. Trigeminal neuralgia diagnosis
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, UNK
Symptoms: Neuralgia, Pain in jaw, Peroneal nerve palsy, Trigeminal neuralgia, Vision blurred
Clinical narrative: Blurry vision, confusion, nerve issues on side of body, ... ended up in er 5x after 3rd vaccine.  Severe head/nerve pain on left side of neck, jaw, face. Left foot drop. Left arm numb.  Slurred speech. Trigeminal neuralgia diagnosis
Age: 77.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Patient reported that her whole arms were swollen and red starting a few hours after getting the shots
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Injection site erythema, Injection site pain, Pain, Pyrexia
Clinical narrative: Fever 102.2, body aches, fatigue, pain and redness at injection site
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Rash
Clinical narrative: pt claimed that she got skin rash on her arm and I advised her to take otc Benadryl and if it got worse she will need to go to er or call 911
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Diplopia
Clinical narrative: Patient called on 9/15/22 at 8pm to say that he had read up side effects of Zostavax that said it could cause blurred vision and blindness.  I explained to him he did not get Zostavax (a live vaccine)  but Shingrix but he insisted that he had double vision since the vaccination. He added that he did see the eye doctor and called his physician. When asked what the optometrist find, he replied that she said everything was normal and could not find anything wrong in his eyes and suggested for him to use artificial tears just in case his eyes are dry.  When asked what the doctor said to him, he also replied that the doctor did not find anything wrong either but told him not to get the second dose.  I told him to use artificial tears as advised by the eye doctor and give it a couple days to see if there is any improvements and notify us later if there is any issue.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Asthenia, Blood iron decreased, Fatigue, Serum ferritin
Clinical narrative: Developed extreme fatigue, weakness, anemia, low iron levels which lasted for months. Recovered after several months of taking liquid iron supplement as recommended per physician.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Asthenia, Blood iron decreased, Fatigue
Clinical narrative: Developed fatigue, weakness, anemia symptoms, low iron symptoms
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Asthenopia, Muscular weakness
Clinical narrative: severe weakness from both thighs to both lower legs, heaviness to both eyes , generalized weakness of body , most  affected is lower extremities.
Age: 53.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nausea
Clinical narrative: Nausea
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lethargy, Myalgia, Nausea
Clinical narrative: Nausea, muscles aches, lethargy
Age: 4.0
Sex: M
Vaccine: COVID19, DTAPIPV, FLUC4, MMRV
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Concern for Covid vaccine given on 9/8/22.  Nurse took thawed vial out of refrigerator and diluted with .7ml of sterile diluent that is normally used to dilute the Proquad/MMR/Varicella. Nurse withdrew .2 ml from vial and administered. Wrong diluent used with incorrect amount of diluent. Patient parent notified on 9/8/22 and informed to notify MD of any type of reaction.  None has been reported as of 9/10/22.
Age: 79.0
Sex: F
Vaccine: FLU4, PNC20, VARZOS
Symptoms: Adverse reaction, Anuria, Anxiety, Chills, Dizziness
Clinical narrative: Adverse reaction to the Shingles vaccination. vaccine card does not show the brand or manufacture of the vaccinations given. Right arm was sore. about 1 hour after injection stated with chills, and physically shaking as if very cold/freezing cold, very anxious to get warm, fell asleep (about 4 hours), no urine or defection for 12 hours even after drinking plenty of fluids upon waking. Arm swelled from injection to elbow and skin was very taught(swelling increase for 2 days), used ice packs to help reduce swelling (didn't work). Inside of arm was very red, hot to touch. Felt dizzy for about 2 days after injection. Arm is still sore 9/10/2022, sore to raise arm. Can feel lumps in the muscles above the elbow on the inside of the arm.
Age: 79.0
Sex: F
Vaccine: FLU4, PNC20, VARZOS
Symptoms: Erythema, Feeling cold, Infrequent bowel movements, Injection site swelling, Muscle mass
Clinical narrative: Adverse reaction to the Shingles vaccination. vaccine card does not show the brand or manufacture of the vaccinations given. Right arm was sore. about 1 hour after injection stated with chills, and physically shaking as if very cold/freezing cold, very anxious to get warm, fell asleep (about 4 hours), no urine or defection for 12 hours even after drinking plenty of fluids upon waking. Arm swelled from injection to elbow and skin was very taught(swelling increase for 2 days), used ice packs to help reduce swelling (didn't work). Inside of arm was very red, hot to touch. Felt dizzy for about 2 days after injection. Arm is still sore 9/10/2022, sore to raise arm. Can feel lumps in the muscles above the elbow on the inside of the arm.
Age: 79.0
Sex: F
Vaccine: FLU4, PNC20, VARZOS
Symptoms: Pain, Pain in extremity, Skin tightness, Skin warm, Tremor
Clinical narrative: Adverse reaction to the Shingles vaccination. vaccine card does not show the brand or manufacture of the vaccinations given. Right arm was sore. about 1 hour after injection stated with chills, and physically shaking as if very cold/freezing cold, very anxious to get warm, fell asleep (about 4 hours), no urine or defection for 12 hours even after drinking plenty of fluids upon waking. Arm swelled from injection to elbow and skin was very taught(swelling increase for 2 days), used ice packs to help reduce swelling (didn't work). Inside of arm was very red, hot to touch. Felt dizzy for about 2 days after injection. Arm is still sore 9/10/2022, sore to raise arm. Can feel lumps in the muscles above the elbow on the inside of the arm.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Seven year old male patient was at the clinic with his father. He was here for the Pfizer peds second doses. The writer went to pick up the pre-drawn vaccination. The writer communicated with the team lead.  The team lead was middle of drawing vaccines. The team lead pointed at the 1 inch vaccine. It was a  baby Moderna vaccine. The 7 year old received the second baby Moderna vaccine instead of the peds Pfizer dose. The POD managers are aware. Child had no adverse effects. The child was observed for 30 mins post vaccination. Checked with CDC for the protocol for this event.  the CDC advised to administer the correct dose. Family has already left the facility after 30 mins. The client did not receive  any additional vaccines.
Age: 8.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was administered the incorrect vaccine/dose.  Patient was supposed to receive a Pfizer booster for the 5y to 11y age group and was given .3ml of the Pfizer Bivalent booster. Patient did not report adverse reactions to staff after receiving the vaccine.
Sex: U
Vaccine: PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: Customer called and reported that a dose of PNEUMOVAX 23 expired on 6/22/2022 and was administered on 8/4/2022. The vaccine had no previous temperature excursion. No additional AE reported. No PQC reported. No additional information provided.; Customer called and reported that a dose of PNEUMOVAX 23 expired on 6/22/2022 and was administered on 8/4/2022. The vaccine had no previous temperature excursion. No additional AE reported. No PQC reported. No additional information provided.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided.   On 04-AUG-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # T034630, expiration date: 22-JUN-2023, 0.5 ml, strength and route of administration were unknown) for prophylaxis (expired product administered). There was no previous temperature excursion reported. No additional adverse event (AE) was reported.
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: Product storage error
Clinical narrative: HCP called for temperature stability evaluation of vaccines and reported that 10 pediatric patients received PROQUAD vaccine since excursion date on 7/14/2022.; This spontaneous report was received from a medical assistant referring to a 4-year-old female patient. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided.   On an unknown date in 2022, the patient was vaccinated with the a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (rHA) (PROQUAD) subcutaneous injection, 0.5 milliliter, once (lot number W016358, expiration date 16-NOV-2023) (route of administration and anatomical location were not provided) as prophylaxis. According to the temperature stability evaluation of vaccines, the vaccine administered had been suffered a temperature excursion since 14-JUL-2022, no exact dates provided (Product storage error).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2208USA004086: US-009507513-2208USA004135: US-009507513-2208USA004105: US-009507513-2208USA004255: US-009507513-2208USA003812: US-009507513-2208USA003988: US-009507513-2208USA004011: US-009507513-2208USA004012: US-009507513-2208USA004060: